Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Most loved Web-based feature: Which Stage Do You Like- See a half-lit moon shine among the stars of Aquarius on Nov. 27
- Kidneys from Black donors are more likely to be thrown away − a bioethicist explains why
- Former 'Bachelorette' welcomes 1st baby via emergency c-section
- Euclid space telescope sees gorgeous cosmic cloud | Space photo of the day for Nov. 18, 2025
- Rick Steves' Favorite Time To Visit Spain Has Lower Prices And Fewer Crowds
- Turning into a Sharp Financial backer: Individual budget Wins
- Australia’s post-Bondi crackdown accused of targeting pro-Palestinian voices
- Want to make America healthy again? Stop fueling climate change
